AMANDA BAKER: Open Payments
NPI 1629498423 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 10 payments from 5 companies in 2025. Trend: 2023 $111 · 2024 $36 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $107 |
| Janssen Biotech, Inc. | 1 | $25 |
| Sage Therapeutics, LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Veozah, TREMFYA, ZURZUVAE, MYFEMBREE, NUCALA.
Industry payments across PA — which companies pay providers there.
